IDO1 and neoplasm: Based on complementary RNA data, nCRT increased IFNγ expression in tumor cells, perhaps as a result of the increased influx of cytotoxic T lymphocytes to balance the immune response by inducing tumor cells to express checkpoint molecules like PD-L1 and Indoleamine 2,3-Dioxygenase (IDO) (60).